Incidence and clinical characteristics of amyotrophic lateral sclerosis during the post-COVID-19 Period: a population-based study from Isfahan, Iran
- 14 August 2026
- journal article
- research article
- Published by Taylor & Francis in Neurodegenerative Disease Management
- p. 1-8
Abstract
1. Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative illness that causes lower motor neurons in the brainstem and spinal cord and upper motor neurons in the motor cortex to los...Keywords
This publication has 38 references indexed in Scilit:
- Neurodegeneration and the immune system: lessons from autoimmune encephalitisJournal of Neurology, 2025
- Examining vaccination-related adverse events in frequent neurodegenerative diseasesBrain, Behavior, & Immunity - Health, 2024
- Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventionsBiomedicine & Pharmacotherapy, 2022
- Incidence of amyotrophic lateral sclerosis in older adultsMuscle & Nerve, 2022
- A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19Inflammopharmacology, 2022
- Arginine vasopressin and pathophysiology of COVID-19: An innovative perspectiveBiomedicine & Pharmacotherapy, 2021
- COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?Journal of Neurology, 2020
- Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysisJournal of Neurology, 2019
- The frontotemporal syndrome of ALS is associated with poor survivalJournal of Neurology, 2016
- Immune-mediated processes in neurodegeneration: where do we stand?Journal of Neurology, 2016